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Background: Expansion of aquaculture requires alternative feeds and breeding strategies to reduce dependency
on fish oil (FO) and better utilization of dietary vegetable oil (VO). Despite the central role of intestine in
maintaining body homeostasis and health, its molecular response to replacement of dietary FO by VO has been
little investigated. This study employed transcriptomic and proteomic analyses to study effects of dietary VO in two
family groups of Atlantic salmon selected for flesh lipid content, 'Lean' or 'Fat'.
Results: Metabolism, particularly of lipid and energy, was the functional category most affected by diet. Important
effects were also measured in ribosomal proteins and signalling. The long-chain polyunsaturated fatty acid
(LC-PUFA) biosynthesis pathway, assessed by fatty acid composition and gene expression, was influenced by
genotype. Intestinal tissue contents of docosahexaenoic acid were equivalent in Lean salmon fed either a FO or VO
diet and expression of LC-PUFA biosynthesis genes was up-regulated in VO-fed fish in Fat salmon. Dietary VO
increased lipogenesis in Lean fish, assessed by expression of FAS, while no effect was observed on β-oxidation
although transcripts of the mitochondrial respiratory chain were down-regulated, suggesting less active energetic
metabolism in fish fed VO. In contrast, dietary VO up-regulated genes and proteins involved in detoxification,
antioxidant defence and apoptosis, which could be associated with higher levels of polycyclic aromatic
hydrocarbons in this diet. Regarding genotype, the following pathways were identified as being differentially
affected: proteasomal proteolysis, response to oxidative and cellular stress (xenobiotic and oxidant metabolism and
heat shock proteins), apoptosis and structural proteins particularly associated with tissue contractile properties.
Genotype effects were accentuated by dietary VO.
Conclusions: Intestinal metabolism was affected by diet and genotype. Lean fish may have higher responsiveness
to low dietary n-3 LC-PUFA, up-regulating the biosynthetic pathway when fed dietary VO. As global aquaculture
searches for alternative oils for feeds, this study alerts to the potential of VO introducing contaminants and
demonstrates the detoxifying role of intestine. Finally, data indicate genotype-specific responses in the intestinal
transcriptome and proteome to dietary VO, including possibly structural properties of the intestinal layer and
defence against cellular stress, with Lean fish being more susceptible to diet-induced oxidative stress.* Correspondence: sofia.morais@irta.cat
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Fish are important components of the human diet, being
highly nutritious and valued as the main source of n-3
long-chain polyunsaturated fatty acids (LC-PUFA).
These essential fatty acids, mainly eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA), have well-
known health-promoting properties, including protec-
tion against a range of cardiovascular and inflammatory
diseases, and neurological disorders [1]. With population
growth and increasing awareness of the importance of
fish consumption as part of a healthy diet, worldwide de-
mand for seafood continues to grow. However, as trad-
itional fisheries are largely in decline, aquaculture must
meet this demand. Aquaculture is the fastest-growing
food production sector with an average annual growth
rate of 6.6%, accounting for 46% of total fish supply [2].
In the European and American continents, aquaculture
production is largely dominated by salmonid species,
mainly Atlantic salmon, and feeds for such carnivorous
species have traditionally relied on fishmeal (FM) and
fish oil (FO) from wild stocks. Recent estimates indi-
cated that 88.5% of global production of FO was used by
the aquaculture sector, with salmonid culture taking the
largest share (56%) [3]. With ever increasing demands
for aquafeeds and reduction in fisheries landings, the
availability of FO and FM seriously limits the growth of
aquaculture production and there is an urgent need to
find more sustainable alternatives.
Vegetable oils (VO) can replace FO in salmon feeds
without compromising fish growth or condition al-
though, at high levels of replacement, tissue levels of n-3
LC-PUFA are significantly reduced [4,5]. The effects of
FO replacement by VO are becoming well characterized
in the hepatic transcriptome of salmonids [6-10], and
other species [11]. However, studies on intestinal tran-
scriptome are few and restricted to effects of replace-
ment of FM by plant proteins, particularly soybean meal
[12,13], given its potential to cause enteritis. It is now
clear that intestine in salmonids is not simply a site for
reacylation and packaging of dietary lipids but it also has
important roles in fatty acid metabolism, including LC-
PUFA biosynthesis [14,15]. Furthermore, dietary VO can
induce major histological changes in fish enterocytes,
originating mostly from supranuclear lipid droplet for-
mation, possibly due to altered reacylation mechanisms
and decreased phospholipid synthesis [16-18]. In some
cases, these accumulations were large enough to be
deemed pathological [19,20]. A recent study investigat-
ing effects of dietary FO replacement by VO on intes-
tinal transcriptome in Atlantic cod indicated potential
effects on lipid absorption and transport and suggested
morphological and structural changes to the intestinal
muscle layer [21]. Furthermore, both this and a previous
study on Atlantic salmon showed significant effects onexpression of genes involved in cell proliferation and
apoptosis [22]. Therefore, there is indication that intes-
tine may be affected by changes in lipid components of
feed formulations. Given its crucial roles in nutrient ab-
sorption, protection against the entry of pathogens, and
immune function [23], further attention is warranted
and impacts of FO replacement require investigation in
intestine, particularly in salmon where important
changes in diet formulation are already being applied.
This study is a large-scale analysis of the effects of re-
placement of dietary FO by VO on the transcriptome
and proteome of Atlantic salmon intestine. Furthermore,
given recent interest in evaluating genetic selection as a
feasible strategy, in conjunction with changes in com-
mercial feed formulation, to meet worldwide demand for
farmed fish without compromising animal welfare or nu-
tritional value [9,10,24], two groups of Atlantic salmon
families, Lean and Fat, were studied to examine the po-
tential effects of genetic background. This experiment
was performed in parallel with another microarray study
looking at effects in the hepatic transcriptome, analysing
samples from the same individuals [9,10], enabling a glo-
bal and comprehensive assessment of the physiological
and molecular effects of FO replacement by VO in At-
lantic salmon, including potential interactions with
genotype.
Results
Microarray analysis
Two way-ANOVA of the cDNA array dataset returned
1409, 1626 and 862 significant genes for the factors diet,
genotype and diet × genotype interaction, respectively.
Detailed analysis was restricted to the top 100 most sig-
nificant features, which were categorised according to
biological function, based on mammalian homolog
genes. Metabolism, particularly of lipid and energy, was
the functional category most affected by diet accounting
for 39-41% of the top 100 annotated genes (Table 1),
and showing highest diet × genotype interaction (Add-
itional file 1). Diet also impacted translation (17%;
mostly ribosomal proteins) and signalling (17%). In con-
trast, genotype affected less markedly metabolism (21%),
whereas structural proteins (25%; mostly different types
of collagen) and proteins involved in the regulation of
transcription (21%) predominated (Table 2).
Gene Ontology (GO) enrichment analysis was per-
formed on the complete significant lists, enabling identi-
fication of GO terms significantly enriched in the input
entity list, in comparison to the whole array, providing
clues as to which biological processes might be particu-
larly altered in the experimental conditions being com-
pared. It revealed no significant enrichment of GO
terms in the genotype list, while 20 and 7 GO terms
were significantly enriched in the diet and interaction
Table 1 Intestine transcripts corresponding to the top 100 most significant features exhibiting differential expression
between diets
Accession no Gene VO/FO p- value
Lean Fat
Metabolism (39%)
Lipid metabolism (9%)
DW590668 Fatty aldehyde dehydrogenase - 1.1 - 1.2 0.0003
CK888998 Ethanolamine kinase 1 1.2 1.2 0.0008
CK884623 Epidermis-type arachidonate lipoxygenase 3 1.4 1.1 0.0010
CK885725 Protein containing a beta-ketoacyl synthase domain 1.4 1.6 0.0017
AF478472 Delta-5 fatty acyl desaturase 1.2 2.5 0.0019
Energy metabolism/generation of precursor metabolites (11%)
CK885194 Cytochrome c oxidase subunit 5A - 1.2 - 1.1 0.0000
bra_snb_03E12 NADH dehydrogenase subunit 1 - 1.3 - 1.2 0.0000
EG649067 Ubiquinol-cytochrome c reductase core protein 1 - 1.2 - 1.1 0.0004
CK884638 Uncoupling protein - 1.3 −1.3 0.0019
CK890974 Mitochondrial calcium-dependent solute carrier SCaMC-2 - 1.5 1.0 0.0021
EG648806 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 - 1.1 - 1.1 0.0022
Protein and amino acid metabolism (9%)
CK877521 Kunitz-type protease inhibitor 2 precursor 1.2 1.1 0.0002
DW590246 Betaine aldehyde dehydrogenase - 1.4 - 1.0 0.0005
CK885180 Fumarylacetoacetate hydrolase domain-containing protein 2B - 1.4 - 1.3 0.0007
CK897653 Ubiquitin-conjugating enzyme E2 A 1.2 1.2 0.0012
CK885145 Lysosomal protective protein precursor (Cathepsin A) 1.1 1.1 0.0014
Carbohydrate metabolism (5%)
EG649263 Endosulfine alpha - 1.3 - 1.0 0.0005
CK885545 Glucose transporter type 8 1.0 1.5 0.0013
Xenobiotic and oxidant metabolism (5%)
CK885392 Catalase 1.6 1.1 0.0000
CO472279 Cytochrome P450 1a 1.2 1.4 0.0004
CK898307 Selenoprotein H-like protein 1.3 1.1 0.0013
Transport/ intracellular trafficking (5%)
EG647578 Calcium-activated potassium channel subunit alpha 1 1.3 1.2 0.0005
EG648841 Sodium-coupled neutral amino acid transporter 2 - 1.2 - 1.2 0.0007
EG648303 Mitochondrial import receptor subunit TOM20 homolog - 1.1 - 1.1 0.0011
Regulation of transcription (13%)
CK898304 C-Maf 1.6 1.6 0.0000
CK890154 Butyrate response factor 2 1.6 1.2 0.0001
EG647831 Proliferation-associated 2G4 b - 1.3 - 1.2 0.0003
AM041851 Enhancer trap locus homolog 1 - 1.1 - 1.2 0.0004
CK885179 Steroid receptor RNA activator 1 - 1.3 - 1.3 0.0007
CK884728 Butyrate response factor 1 1.1 1.4 0.0011
CK879187 Enhancer of polycomb homolog 1 1.4 1.1 0.0020
Translation (17%)
CK878380 40S ribosomal protein S18 - 1.1 - 1.2 0.0003
DW591873 60S acidic ribosomal protein - 1.3 - 1.2 0.0006
Morais et al. BMC Genomics 2012, 13:448 Page 3 of 21
http://www.biomedcentral.com/1471-2164/13/448
Table 1 Intestine transcripts corresponding to the top 100 most significant features exhibiting differential expression
between diets (Continued)
EG648644 60S ribosomal protein L29 - 1.1 - 1.2 0.0011
DW590580 40S ribosomal protein S5 - 1.2 - 1.2 0.0011
CK880046 40S ribosomal protein S28 - 1.1 - 1.2 0.0017
EG649167 60S ribosomal protein L37a - 1.1 - 1.2 0.0017
EG648512 60S ribosomal protein L41 - 1.1 - 1.2 0.0017
CK886042 60S ribosomal protein L31 - 1.1 - 1.3 0.0021
CK895350 60S ribosomal protein L36 - 1.1 - 1.1 0.0021
Signalling/Signal transduction (17%)
CK874863 Proto-oncogene serine/threonine-protein kinase 1.1 1.1 0.0002
CK881266 Mitogen-activated protein kinase kinase kinase kinase 1 1.2 1.2 0.0002
CK878590 Serine/threonine protein kinase (Tribbles homolog 2) - 1.1 - 1.3 0.0004
AJ425351 Tensin-like C1 domain-containing - 2.0 - 1.2 0.0006
CK885079 Sonic hedgehog-like protein 1.3 1.0 0.0008
CN181161 TGF-beta type II receptor 1.1 1.1 0.0009
EG649257 Serine/threonine-protein kinase VRK3 - 1.1 - 1.2 0.0009
CK886267 Guanylate cyclase 2C 1.1 1.1 0.0011
CK884467 Serine/threonine-protein phosphatase 2A regulatory subunit B - 1.4 - 1.3 0.0020
Structural proteins (7%)
mus_snm_13F09 Myosin heavy chain - 1.2 - 1.1 0.0002
CK885118 Cardiac tropomyosin 1.0 1.1 0.0013
CK883354 Troponin C 1.2 1.2 0.0017
EG647866 Tubulin alpha chain - 1.2 - 1.2 0.0020
Immune response (2%)
BM414177 Liver-expressed antimicrobial peptide 2 1.5 1.4 0.0022
Miscellaneous
CK884634 Ezrin-radixin-moesin binding phosphoprotein 50 1.1 1.1 0.0003
EG648821 Transposase - 1.1 - 1.2 0.0004
CK883634 Poly [ADP-ribose] polymerase 12 1.3 1.1 0.0006
CK885090 Claudin 15 1.2 1.1 0.0008
DW589291 Transposase - 1.3 - 1.3 0.0009
CK878888 Splicing factor, arginine/serine-rich 3 - 1.3 - 1.2 0.0013
CK885098 RNA-binding protein with multiple splicing 2 - 1.4 - 1.2 0.0013
CK891747 Occludin - 1.2 - 1.2 0.0014
CK888908 All-trans-retinol 13,14-reductase precursor 1.1 1.2 0.0017
CK880622 Cyclin G1 - 1.1 - 1.2 0.0019
CK885604 Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like - 1.6 - 1.3 0.0020
CK891699 Barrier-to-autointegration factor - 1.1 - 1.2 0.0020
CK879123 Hemoglobin subunit beta 1.5 1.0 0.0022
Annotated features (67% of all clones) are arranged by categories of biological function (with percentages of distribution of genes within each category being
indicated) and, within these, by decreasing significance (assessed by two-way ANOVA). Also indicated are the GenBank accession numbers for each clone (or,
when not available, the probe number) and the expression ratio between fish fed VO and those fed FO, for each genotype (Lean and Fat).
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included structural constituents of ribosome, structural
molecule activity, cytosolic ribosome, cytosol, ribosomal
subunit, translation, cellular biosynthetic process, geneexpression, macromolecule and biopolymer biosynthetic
process and other related terms. This was explained by
the large number of ribosomal proteins, components of
both the 40S and 60S subunits, which were down-
Table 2 Intestine transcripts corresponding to the top 100 most significant features exhibiting differential expression
between family groups
Accession no Gene Lean/Fat p- value
FO VO
Metabolism (21%)
Lipid metabolism (5%)
CK874747 Acylglycerol kinase - 1.0 - 1.1 0.0003
BI468033 ATP-binding cassette sub-family A member 1 - 1.1 - 1.6 0.0004
Energy metabolism/generation of precursor metabolites (2%)
CK890974 Mitochondrial calcium-dependent solute carrier SCaMC-2 - 1.1 - 1.6 0.0000
Protein and amino acid metabolism (12%)
EG647485 Proteasome subunit beta type-8 precursor - 1.3 - 1.8 0.0000
DW591059 Heat shock protein Hsp-16 1.2 1.4 0.0001
AJ425553 26S proteasome non-ATPase regulatory subunit 9 - 1.2 - 1.1 0.0002
DW592187 26 proteasome complex subunit DSS1 1.5 1.3 0.0008
CK878109 Heat shock protein 60 kDa 1.2 1.4 0.0009
Xenobiotic and oxidant metabolism (2%)
CO472279 Cytochrome P450 1A - 1.2 - 1.5 0.0003
Transport/ intracellular trafficking (5%)
CK886307 Peptide transporter PEPT2 - 1.4 - 1.3 0.0006
DW588251 Post-GPI attachment to proteins factor 2 1.1 1.3 0.0007
Regulation of transcription (21%)
CK877881 Forkhead box Q1 - 1.4 - 1.7 0.0000
CK884548 Proline-rich nuclear receptor coactivator 2 - 1.1 - 1.2 0.0001
CK885013 Forkhead box protein F1 1.1 1.5 0.0003
CK891975 Y-box binding protein-2 - 1.1 - 1.1 0.0003
DW589341 Signal transducer/activator of transcription Stat1 - 1.2 - 1.2 0.0004
CN181282 Bromodomain containing protein 3 - 1.1 - 1.1 0.0007
CK884407 C-Myc-binding protein - 1.3 - 1.1 0.0007
CK895950 Transcription factor CP2-like - 1.5 - 1.2 0.0007
EG648473 BTB/POZ domain-containing protein - 1.1 - 1.4 0.0009
Translation (7%)
CN181322 40S ribosomal protein S4 1.1 1.1 0.0002
CK885979 Ribonuclease UK114 - 1.1 - 1.3 0.0005
EG648042 Eukaryotic translation initiation factor 3, subunit J 1.1 1.1 0.0009
Signalling/Signal transduction (16%)
CO471793 Rho GDP-dissociation inhibitor 1 1.3 1.0 0.0000
CK885560 Protein tyrosine phosphatase non-receptor type 9 1.3 1.5 0.0004
CK885079 Sonic hedgehog-like protein - 1.3 - 1.0 0.0004
EG648038 Kalirin, RhoGEF kinase 1.2 1.2 0.0005
DW589610 Chimaerin 1 1.2 1.2 0.0005
CK897590 Growth factor receptor-bound protein 2 1.1 1.1 0.0009
EG647545 Protein tyrosine phosphatase receptor type D 1.0 1.2 0.0009
Structural proteins (25%)
CK882401 Troponin C - 1.1 - 1.2 0.0000
CK889952 Transgelin 2 1.5 1.7 0.0000
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Table 2 Intestine transcripts corresponding to the top 100 most significant features exhibiting differential expression
between family groups (Continued)
EG648135 Osteonectin 1.3 1.5 0.0000
CK899058 Collagen alpha 3 type VI 1.5 1.5 0.0002
CK879405 Collagen alpha 2 type VI 1.3 1.5 0.0002
EG649361 Collagen alpha 2 type I 1.5 1.7 0.0005
EG649013 Collagen alpha 3 type I 1.4 1.5 0.0005
mus_mfo_15A10 Troponin-I isoform 3 1.4 1.6 0.0007
CK876833 Keratocan - 1.0 1.6 0.0007
DW590534 Collagen alpha 2 type I 1.5 1.6 0.0010
CK892271 Collagen alpha 2 type V 1.2 1.4 0.00010
CK873441 Collagen alpha1 type VI 1.2 1.4 0.0010
Immune response (5%)
AJ425527 T-cell immunoglobulin and mucin domain-containing protein 4 1.1 1.1 0.0001
EG649194 Mannose-binding protein C 1.4 1.4 0.0003
Miscellaneous
AM041770 Preimplantation protein 3 - 1.3 - 1.2 0.0000
EG649106 Ornithine decarboxylase antizyme 2 1.4 1.1 0.0002
CK884355 Guanylin precursor 1.2 1.4 0.0002
CK879185 Aminolevulinate, delta-, synthetase 1 - 2.0 - 1.1 0.0002
CK885814 Similar to p53-associated parkin-like cytoplasmic protein 1.2 1.1 0.0002
CK886214 Septin-7 1.1 1.1 0.0003
BM414079 Tumor protein D52-like 2 - 1.1 - 1.3 0.0003
BM413818 Splicing factor, proline- and glutamine-rich 1.2 1.2 0.0003
CK874550 Follistatin-related protein 1 1.1 1.3 0.0004
DW589104 Nucleoside diphosphate kinase 6 1.1 1.1 0.0005
DW592207 Deoxyhypusine synthase 1.5 1.6 0.0007
CK892359 HCLS1-associated protein X-1 - 1.2 - 1.1 0.0007
BI468158 Nuclear protein 1 - 1.0 - 1.6 0.0009
AJ425003 Lamina-associated polypeptide 2 1.2 1.1 0.0010
CK899283 Small EDRK-rich factor 2 1.3 1.5 0.0010
CK885090 Claudin 15 - 1.2 - 1.1 0.0011
Annotated features (60% of all clones) are arranged by categories of biological function (with percentages of distribution of genes within each category being
indicated) and, within these, by decreasing significance (assessed by two-way ANOVA). Also indicated are the GenBank accession numbers for each clone (or,
when not available, the probe number) and the expression ratio between Lean and Fat fish fed either FO or VO.
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Δ6-desaturase (Δ6fad) clones showing a diet × genotype
interaction (see Additional file 1) caused a significant en-
richment of the GO terms oxidoreductase activity,
stearoyl-CoA 9-desaturase activity, unsaturated fatty acid
biosynthetic activity/metabolic processes and very long
chain fatty acid (VLCFA) biosynthetic activity/metabolic
processes.
RT-qPCR analysis of gene expression
The expression of several genes significantly affected or
related to processes affected by the two factors in the
microarray analysis was determined by RT-qPCR
(Table 3). For diet, a reasonably good match was foundfor Δ5 fatty acyl desaturase (Δ5fad), NADH dehydrogen-
ase subunit 1 (NADH1), proliferation-associated 2G4b
(PA2G4), 60S acidic ribosomal protein (RP60S), prolifer-
ating cell nuclear antigen (PCNA; also known as cyclin)
and cytochrome P450 1A (CYP1A), particularly in the
Fat group where fold-changes were generally more pro-
nounced and significant. No change in expression of un-
coupling protein 2 (UCP2) with diet was measured
while, for myosin heavy chain (MYO) and methylenete-
trahydrofolate dehydrogenase (NADP+ dependent) 1-
like (MTHFD1), RT-qPCR indicated a change opposite
to that suggested by microarray. Regarding genotype, a
good match was obtained for CYP1A, proteasome sub-
unit beta type-8 precursor (PSMB8) and alpha 2 type I
Table 3 Relative expression of genes assayed by RT-qPCR
Genes VO/FO Lean/Fat
Lean Fat FO VO
Ratio p value Ratio p value Ratio p value Ratio p value
Microarray validation
Δ5fad (D) 1.72 ns 4.34 0.005 2.49 ns −1.01 ns
NADH1 (D) −1.03 ns −1.28 0.05 1.00 ns 1.24 ns
UCP2 (D) −1.10 ns 1.08 ns −1.10 ns −1.28 0.003
MTHFD1 (D) 1.20 ns −1.09 ns −1.08 ns 1.22 ns
PA2G4 (D) −1.27 ns −1.23 0.032 1.11 ns 1.1 ns
RP60S (D) −1.02 ns −1.69 0.023 1.13 ns 1.9 0.006
MYO (D) 1.77 0.034 1.22 ns −1.35 ns 1.08 ns
PCNA (D) −1.14 ns −1.27 ns 1.08 ns 1.20 ns
CYP1A (D+G) 1.71 0.004 1.81 0.023 −2.22 0.003 −2.38 0.001
ABCA1 (G) 1.24 ns 1.17 ns 1.21 ns 1.28 0.015
PSMB8 (G) −100.00 ns 1.87 0.033 −16.67 0.026 < −1000 0.000
TAGLN (G) 1.23 ns −1.02 ns −1.03 ns 1.22 ns
COL1A2 (G) 1.31 ns −1.06 ns 1.47 ns 2.06 0.001
LC-PUFA biosynthesis and regulation
Δ6fad_a 1.11 ns 2.96 0.008 1.76 ns −1.52 ns
elovl5a 1.08 ns 1.2 ns 1.03 ns −1.08 ns
elovl5b −1.19 ns 1.92 0.031 1.54 ns −1.47 ns
elovl2 1.2 ns 14.74 0.003 4.89 ns −2.50 ns
Fatty acid synthesis
FAS 1.49 0.010 1.20 ns 1.05 ns 1.31 ns
Fatty acid oxidation
ACO 1.18 ns 1.28 ns 1.19 ns 1.09 ns
CPT1 1.23 ns −1.09 ns −1.16 ns 1.15 ns
Regulation of lipid metabolism
PPARα 1.14 ns 1.38 ns 1.26 ns 1.04 ns
PPARβ 1.03 ns 1.03 ns −1.02 ns −1.02 ns
PPARγ 1.52 ns 1.60 0.036 1.21 ns 1.15 ns
Xenobiotic and oxidative stress
GST −1.30 ns 1.07 ns 1.21 ns −1.14 ns
MT-A −1.82 0.051* −1.05 ns −1.25 ns −2.13 0.007
CAT 1.57 0.036 1.26 ns −1.52 ns −1.22 ns
SOD −1.20 ns −1.04 ns 1.21 ns 1.04 ns
Apoptosis
CASP3B 1.22 0.045 1.22 ns −1.04 ns −1.04 ns
CASP6A/B 1.30 ns 1.37 ns −1.14 ns −1.20 ns
fad: Fatty acyl desaturase (Δ5 and Δ6 activities); NADH1: NADH dehydrogenase subunit 1; UCP2: Uncoupling protein 2; elovl: MTHFD1: Methylenetetrahydrofolate
dehydrogenase (NADP+ dependent) 1-like; PA2G4: Proliferation-associated 2G4b; RP60S: 60S acidic ribosomal protein; MYO: Myosin heavy chain; PCNA:
Proliferating cell nuclear antigen; CYP1A: Cytochrome P4501A; ABCA1: ATP-binding cassette sub-family A member 1; PSMB8: Proteasome subunit beta type-8
precursor; TAGLN: Transgelin 2; COL1A2: Collagen type I alpha 2; elovl2: Elongase 2; FAS: Fatty acid synthase; ACO: Acyl-CoA oxidase; CPT1: Carnitine
palmitoyltransferase I; PPARs; Peroxisome proliferator-activated receptors; GST: glutathione S-transferase; MT-A: Metallothionein A; CAT: catalase; SOD: superoxide
dismutase; CASP; caspase.
*Only marginally non-significant.
Genes correspond to features significantly affected by either diet (D) or genotype (G) in the microarray analysis or involved in biological processes being analysed
in further detail. Values are normalized (by cofilin-2 and elf-1 α) gene expression ratios between fish fed VO in relation to FO for each family group or of Lean fish
in relation to the Fat group when fed either one of the diets. Values in bold are significantly different, at p<0.05 (REST 2008); ns - non-significant.
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sion did not differ between family groups, and for ATP-
binding cassette sub-family A member 1 (ABCA1) there
was an inverse change in expression.
As well as validation above, RT-qPCR was used to fur-
ther analyse genes/pathways identified by microarray and
published data as potentially interesting, including lipid
metabolism, xenobiotic and oxidative stress, and apoptosis.
One was LC-PUFA biosynthesis, given that Δ5fad was sig-
nificantly affected by diet in the microarray analysis, with a
stronger response in Fat fish, whereas Δ6fad showed a sig-
nificant diet × genotype interaction (supplementary file 1)
confirmed by RT-qPCR. The Δ6fad transcript was only sig-
nificantly up-regulated in Fat fish fed VO, compared to
FO, and Lean fish showed higher levels of Δ6fad expres-
sion than Fat fish when fed FO, while the opposite trend
was noted when fish were fed VO. Fatty acyl elongases
(elovl’s) were also quantified and their expression (except
elovl5a) broadly followed that of fads: significantly up-
regulated when dietary VO replaced FO in the Fat group.
Additionally, elovl5b and, particularly, elovl2 showed a
trend for increased expression (high fold-change) in Lean
fish, compared to Fat fish, when fed FO, while an oppositeTable 4 Fatty acid compositions (% of total fatty acids) and li
Lean and Fat family groups fed diets containing either FO or
FO
Fat Lean Fat
Fatty acid
Total saturated 23.70 ± 1.21 22.82 ± 1.09 18.57 ±
Total monoenes 38.25 ± 7.15 44.45 ± 5.31 44.98 ±
18:2n-6 4.19 ± 0.67 4.51 ± 0.24 13.14 ±
18:3n-6 0.10 ± 0.02 0.10 ± 0.02 0.28 ±
20:2n-6 0.57 ± 0.06 0.58 ± 0.07 1.54 ±
20:3n-6 0.17 ± 0.06 0.14 ± 0.02 1.01 ±
20:4n-6 1.20 ± 0.60 0.85 ± 0.31 0.74 ±
22:4n-6 0.08 ± 0.06 0.05 ± 0.06 0.00 ±
22:5n-6 0.21 ± 0.06 0.16 ± 0.07 0.07 ±
Total n-6 PUFA 6.51 ± 0.18 6.38 ± 0.36 16.79 ±
18:3n-3 1.46 ± 0.38 1.67 ± 0.21 4.79 ±
18:4n-3 1.36 ± 0.60 1.67 ± 0.66 0.85 ±
20:3n-3 0.27 ± 0.05 0.33 ± 0.14 0.67 ±
20:4n-3 1.77 ± 0.28 2.16 ± 0.46 0.97 ±
20:5n-3 6.55 ± 0.55 5.79 ± 0.62 3.60 ±
22:5n-3 2.82 ± 0.81 2.30 ± 0.74 1.57 ±
22:6n-3 16.68 ± 6.68 11.65 ± 5.65 6.97 ±
Total n-3 PUFA 30.90 ± 5.94 25.56 ± 5.19 19.41 ±
Total PUFA 38.06 ± 5.96 32.73 ± 5.42 36.45 ±
Total lipids 7.50 ± 3.75 9.56 ± 3.81 6.97 ±
Results are means ± SD (n = 4) and p-values of two-way ANOVA are presented fortrend was observed when salmon were fed VO. Although
genes involved in fatty acid synthesis and oxidation showed
few significant differences, expression of fatty acid synthase
(FAS) was up-regulated in fish fed VO, but only in Lean
fish. The expression of peroxisome proliferator-activated
receptors (PPARs), involved in the regulation of multiple
lipid metabolism genes, was determined but only PPARγ
showed any significant change, being up-regulated in the
Fat group when dietary VO replaced FO. Of the xenobiotic
and oxidativemetabolism genes assayed, apart fromCYP1A,
only catalase (CAT) was affected by diet (up-regulated in
fish fed VO) and only significantly in the Lean family. In
contrast, metallothionein A (MT-A) showed higher expres-
sion in Fat fish, but only when fed VO, while a marginal
down-regulation was observed when comparing VO and
FO-fed fish in the Lean group. Of genes related to apoptosis,
CASP3B was up-regulated by VO in Lean fish whereas a
similar fold-change was marginally non-significant in the
Fat fish.
Intestine fatty acid composition
The levels of most fatty acids in pyloric caeca were
affected by diet, whereas genotype had no significantpid contents (% of wet weight) of intestinal tissue of
VO
VO Two-way ANOVA
Lean D G D×G
0.73 20.08 ± 1.38 0.000 0.742 0.066
2.38 39.34 ± 4.49 0.717 0.928 0.046
0.59 11.28 ± 1.12 0.000 0.139 0.041
0.12 0.25 ± 0.13 0.003 0.611 0.611
0.40 1.65 ± 0.06 0.000 0.199 0.510
0.12 1.47 ± 0.26 0.000 0.056 0.019
0.18 1.40 ± 0.29 0.785 0.419 0.016
0.00 0.09 ± 0.07 0.337 0.337 0.038
0.02 0.12 ± 0.05 0.002 1.000 0.128
0.86 16.27 ± 0.67 0.000 0.410 0.781
0.53 3.71 ± 0.75 0.000 0.211 0.021
0.31 0.55 ± 0.20 0.002 0.712 0.127
0.18 0.62 ± 0.04 0.000 0.768 0.384
0.13 0.83 ± 0.10 0.000 0.504 0.061
0.90 4.40 ± 0.72 0.000 0.682 0.058
0.36 2.54 ± 0.77 0.157 0.530 0.052
1.58 11.50 ± 3.10 0.057 0.943 0.050
2.18 24.15 ± 3.76 0.015 0.962 0.042
2.08 40.59 ± 3.16 0.206 0.794 0.059
1.07 4.59 ± 1.05 0.081 0.804 0.111
diet (D), genotype (G) and interaction between both factors.
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http://www.biomedcentral.com/1471-2164/13/448effect (Table 4). However, some fatty acids also showed a
significant diet × genotype interaction, indicating that
the effect of diet depended on the genetic background of
the fish. For instance, interactions were observed for
some LC-PUFA as a result of higher levels being found
in the Lean group, compared to Fat, when fish were
fed VO, while the reverse was observed when fed FO.
Another unexpected result was that similar levels of
DHA in FO- and VO-fed Lean fish meant that, in
spite of substantial differences in Fat fish fed the two
diets, the effect of diet on DHA was marginally non-
significant. Similarly, levels of EPA and 22:5n-3 be-
tween FO- and VO-fed fish were noticeably closer in
the Lean group.3243 
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Figure 1 Proteins significantly affected by diet or genotype. Cropped
identified as being differentially expressed (P<0.05, two-way ANOVA) in fish
groups (remaining spot numbers); the three underlined spot numbers con
Spots that returned reliable identifications by peptide fragment fingerprintiProteomic analysis
Of the protein spots identified as being differentially
expressed between diets or genotypes (Additional files 2
and 3), only 17 and 29 could be excised and, of these,
only 9 and 20, respectively, returned reliable identifica-
tions by peptide fragment fingerprinting (Figure 1). Pro-
teins significantly up-regulated by dietary VO are likely
implicated in xenobiotic/drug metabolism (epoxide
hydrolase 2, EPHX2), protection from oxidative stress
(hemopexin-like protein, HPX and peroxiredoxin-1,
PRDX1) and induction of apoptosis and inflammatory
responses (galectin-2, LGALS2). Those proteins down-
regulated by dietary VO included proteins responsible for
protein folding and involved in signalling (2-peptidylprolyl3445 
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taining an * were differentially affected by both diet and genotype.
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Table 5 Proteins differentially regulated by diet
Spot No Protein ID Accession No.
(NCBInr)
Theoretical Mw
(KDa)/pI
Protein
Scorea
No. Matched peptides
(MS/MS)b
Best score peptide VO/FO Lean VO/FO Fat p-value
1136 Epoxide hydrolase 2 (EPHX2) gb|ACI33129.1| 54.2/5.52 84 1 GGLFVGLPDEIPR 1.23 1.40 0.0190
1148 Hemopexin-like protein* (HPX) emb|CAA92147.1| 50.4/5.61 169 1 VHLDAITSDDAGNIYAFR 1.32 1.56 0.0002
1151 Hemopexin-like protein* (HPX) ref|NP_001104617.1| 51.0/6.18 161 1 VHLDAITSDDAGNIYAFR 1.38 1.54 0.0001
2683 Peroxiredoxin 1 (PRDX1) gb|ACI67145.1| 22.0/6.42 757 8 SISTDYGVLKEDEGIAYR 1.14 1.09 0.0310
3168 2-peptidylprolyl isomerase A
(PPIA)
ref|NP_001135161.1| 17.5/7.61 101 1 VYFDITIGDTPAGR −1.46 −1.18 0.0170
3243 Myosin light chain smooth
muscle isoform (MYL)
ref|NP_998803.1| 16.9/4.47 100 2 EAFLLFDR −1.23 −1.11 0.0490
3331 similar to H2A histone family,
member J (H2A)
ref|XP_001521566.1| 13.3/10.84 74 1 AGLQFPVGR −1.58 −1.18 0.0250
3334 Histone H2A** (H2A) emb|CAA25528.1| 13.7/10.88 37 1 AGLQFPVGR −1.48 −1.18 0.0210
3445 Galectin 2 (LGALS2) gb|ACN10131.1| 14.8/5.93 314 2 SGASSFSINIGHDSDNYALHFNPR 1.17 1.15 0.0170
a The protein score probability limit (where P < 0.05) is 73.
b Peptides with confidence interval above 95% were considered.
* Equivalent to warm-temperature-acclimation-related-65 kDa-protein.
**Same protein identification obtained by MS/PMF (peptide mass fingerprinting): Score = 76; 7 peptides matched.
Only reliable identifications of Actinopterygii, obtained by mass spectrometry (MALDI-TOF-MS/MS) analysis and searches in MASCOT, NCBI and ExPASy (Mw/pI) databases are shown. Expression ratios between fish fed
VO and FO diets are given for each family group, as well as p-value for diet (two-way ANOVA, DeCyder V7.0).
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Table 6 Proteins differentially regulated by genotype
Spot No Protein ID Accession No.
(NCBInr)
Theoretical Mw
(KDa)/pI
Protein
Scorea
No. Matched peptides
(MS/MS)b
Best score peptide Lean/Fat FO Lean/Fat VO p-value
1148 Hemopexin-like protein* (HPX) emb|CAA92147.1| 50.4/5.61 169 1 VHLDAITSDDAGNIYAFR −1.09 −1.29 0.0270
1389 Calreticulin precursor (CALR) gb|ACI32936.1| 47.6/4.33 81 2 FEPFSNEGK −1.28 −1.33 0.0026
1441 Alpha-enolase (ENO1) ref|NP_001133366.1| 47.0/5.91 405 3 AAVPSGASTGIYEALELR 1.28 1.2 0.0066
1714 Heat shock protein 70 (HSP70) ref|NP_990334.1| 70.8/5.47 111 1 IINEPTAAAIAYGLDKK 1.16 1.77 0.0260
2134 Heterogeneous nuclear
ribonucleoprotein A0 (HNRNPA0)
gb|ACI67551.1| 28.8/9.10 235 2 LFVGGLNVDTDDDGLRK −1.19 −1.09 0.0460
2154 Calponin 1 (CNN1) ref|NP_001139857.1| 33.2/8.56 565 4 KINTSPQNWHQLENIGNFVR −1.34 −1.51 0.0350
2157 Calponin 1*** (CNN1) ref|NP_001139857.1| 33.2/8.56 43 1 YDPQKEEELR −1.34 −1.47 0.0240
2213 Caspase 3 (CASP3) ref|NP_001133393.1| 31.0/5.97 254 2 IPVEADFLYAYSTAPGYYSWR −1.15 −1.24 0.0300
2215 Caspase 3 (CASP3) ref|NP_001133393.1| 31.0/5.97 279 2 VANDQTVQQIQQLLSK −1.14 −1.31 0.0130
2282 Voltage-dependent anion
channel 2–2 (VDAC2)
gb|ACH71030.1| 30.1/8.85 214 1 VNNNSLVGVGYTQTLRPGVK −1.24 −1.19 0.0160
2458 Annexin A4 (ANXA4) gb|ACI69495.1| 28.4/5.22 218 3 NHLLQVFK −1.14 −1.11 0.0300
2487 Dihydropteridine reductase
(DHPR)
gb|ACI67281.1| 15.7/8.46 81 1 QSVWTSTISSHLATR −1.14 −1.11 0.0300
2499 Pancreatic alpha-amylase
precursor (AMY2)
ref|NP_001036176.1| 57.4/6.89 86 1 ALVFVDNHDNQR −1.37 −1.27 0.0021
2522 Triosephosphate isomerase
1b (TPI1)
ref|NP_001133174.1| 26.6/7.63 336 2 LDPNTEVVCGAPSIYLEFAR 1.26 1.16 0.0009
2527 Histone cluster 1 (H2A) ref|NP_001086775.1| 14.0/10.88 94 1 AGLQFPVGR 1.12 1.11 0.0074
2677 Transgelin (TAGLN) gb|ACM09025.1| 21.7/7.69 219 1 DGCVLSELINSLHK −1.61 −1.35 0.0350
2717 Proteasome beta 1 subunit
(PSMB1)
ref|NP_001003889.1| 26.1/6.32 87 1 GAVYSFDPVGSYQR −1.29 −1.12 0.0140
2903 Peroxiredoxin-1(PRDX1) gb|ACI67145.1| 22.0/6.42 115 1 QITINDLPVGR −1.62 −1.99 0.0069
3345 Retinol-binding protein II,
cellular (RBP2)
ref|NP_001139954.1| 15.6/5.44 70 2 AIDIDFATR −1.32 −1.1 0.0330
3457 Alpha globin (HBA) emb|CAA65949.1| 15.1/9.19 170 2 TYFSHWADLSPGSAPVK 1.03 2.09 0.0320
aThe protein score probability limit (where P < 0.05) is 73.
b Peptides with confidence interval above 95% were considered.
* Equivalent to warm-temperature-acclimation-related-65 kDa-protein.
*** Same protein identification obtained by MS/PMF (peptide mass fingerprinting): Score = 193; 27 peptides matched.
Only reliable identifications of Actinopterygii, obtained by mass spectrometry (MALDI-TOF-MS/MS) analysis and searches in MASCOT, NCBI and ExPASy (Mw/pI) databases are shown. Expression ratios between Lean
and Fat family groups are given for each dietary treatment, as well as p-value for genotype (two-way ANOVA, DeCyder V7.0).
M
orais
et
al.BM
C
G
enom
ics
2012,13:448
Page
11
of
21
http://w
w
w
.biom
edcentral.com
/1471-2164/13/448
Morais et al. BMC Genomics 2012, 13:448 Page 12 of 21
http://www.biomedcentral.com/1471-2164/13/448isomerase A, PPIA), actin-based motility (myosin light
chain, MYL) and DNA replication, repair or transcription
(histone H2A, H2A) (Table 5). Proteins affected by geno-
type encompass a variety of pathways, of which only a few
are related to metabolism, namely carbohydrate (alpha-
enolase, ENO1; pancreatic alpha-amylase precursor,
AMY2; triosephosphate isomerase 1b, TPI1), folate (dihy-
dropteridine reductase, DHPR) or retinol (retinol-binding
protein II, RBP2) metabolism (Table 6). Other proteins
may have potentially multiple roles but can broadly be
assigned roles in response to oxidative and cellular stress
(HPX; PRDX; heat shock protein 70, HSP70), oxygen
transport (alpha globin, HBA), signal transduction (calre-
ticulin, CALR), transcription/RNA repair (heterogeneous
nuclear ribonucleoprotein A0, HNRNPA0; histone H2A,
H2A), apoptosis (CASP3), cellular transport, potentially
also associated with apoptosis (voltage-dependent anion
channel 2–2,VDAC2; annexin A4, ANX4), and proteolysis
(proteasome beta 1 subunit, PSMB1). As with the micro-
array analysis, a few proteins with a more structural func-
tion and particularly associated with tissue contractile
properties were affected by genotype, showing lower levels
in Lean fish. These included calponin-1 (CNN1) and
transgelin (TAGLN), the latter which was also found to be
significantly affected by microarray, albeit up-regulated in
Lean fish. Most proteins significantly affected by genotype
showed lower levels of expression in the Lean group, with
the exception of ENO1, HSP70,TPI1, H2A and HBA.
Discussion
Dietary plant ingredients can induce chronic intestinal
inflammatory conditions in salmonids that can ultim-
ately result in carcinogenesis [25]. This extreme reaction
is rare and usually associated with soy protein at high
levels [26]. Dietary n-3 LC-PUFA have important anti-
inflammatory and anti-carcinogenic effects in mamma-
lian intestine [23]. Therefore, use of feeds containing
high percentages of plant proteins combined with re-
placement of FO by VO, as is now prevalent in the in-
dustry, requires studies on dietary effects on intestinal
transcriptomes and proteomes. However, interpretation
of the data was difficult as the effects on dietary treat-
ments and/or family groups were subtle, as also
observed in liver transcriptome [9], and is typical of this
type of experiment [6,8,11,27]. Partly as a consequence,
validation of the microarray data gave variable results,
from perfect match, to opposite changes in a few, al-
though effects observed in the microarray, with fold
changes as low as 1.2 (e.g., NADH1 and PA2G4) were
validated by RT-qPCR. In view of the whole genome du-
plication event that occurred in salmonids [28], gene ex-
pression studies are often more challenging due to the
presence of highly similar genes which may hybridize
with cDNA probes presenting low specificity, furthercomplicated if similar transcripts, corresponding to
duplicated genes, are differentially regulated [10]. None-
theless, the presence of several features related to spe-
cific processes in both the transcriptomic and proteomic
analysis gave supporting evidence to the pathways likely
differentially affected by dietary oil and genetic back-
ground related to flesh adiposity.
Intestinal LC-PUFA biosynthesis capacity is differentially
affected by diet and genotype
Considering whether genetic selection for fish families
showing better adaptation to more sustainable feeds
might be a viable approach to develop aquaculture, one
outcome of this investigation was to establish if effects
of diet on expression of LC-PUFA biosynthesis genes
depended on genotype, as shown in the liver transcrip-
tome of these fish [9]. This was not seen in the hepatic
transcriptome of European sea bass families showing dif-
ferent growth rates when fed a vegetable diet but, in this,
case similar LC-PUFA profiles were also noted in both
genotypes in response to the vegetable diet [11]. In both
salmon tissues, differences in n-3 LC-PUFA content be-
tween fish fed FO or VO were smaller in the Lean family
group. This was due to higher levels of n-3 LC-PUFA in
Lean salmon, compared to Fat, when fish were fed VO,
but higher amounts in the Fat family group when fed
FO. However in liver, up-regulation of LC-PUFA biosyn-
thesis when fish were fed VO was much larger in the
Lean family group, whereas in intestine the same indivi-
duals only showed significant up-regulation in Fat fish.
This appears contradictory but can be explained by the
differential tissue n-3 LC-PUFA contents. Although the
difference was smaller in Lean fish compared to Fat fish
in both tissues, in liver there was still a considerable dif-
ference in n-3 LC-PUFA levels between fish fed FO or
VO, while in intestine levels were similar. PUFA have
important activities on transcription factors, either as
direct ligands or through effects on membrane compos-
ition [29], affecting transcription of many genes involved
in lipid metabolism, including desaturases and elongases
[30,31]. In salmon, regulation of genes of LC-PUFA bio-
synthesis that are known to respond to dietary compos-
ition, i.e., Δ5fad, Δ6fad, elovl5b and elovl2 [32-34],
appear to show high plasticity and are likely under feed-
back regulation by tissue n-3 LC-PUFA. Both studies
suggest that the Lean family group may show an
enhanced response to low dietary n-3 LC-PUFA, with
greater up-regulation of biosynthesis when fed VO. In
contrast to liver, this response was sufficient in intestine
to maintain tissue n-3 LC-PUFA, particularly DHA, at
similar levels to fish fed FO. Considering that differences
in desaturase expression between the Fat and Lean fish
were only significant when FO but not VO, was fed, sug-
gests that the likely mechanism is through negative
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positive feedback from low levels of LC-PUFA and/or
higher levels of shorter chain precursors.
Other dietary effects on lipid metabolism
Transcriptional regulation of desaturases and elongases
by LC-PUFA may involve both PPARα and sterol regula-
tory element binding protein 1c (SREBP-1c) [30,31]. In
liver, expression of Δ5fad, Δ6fad, elovl2, PPARα, and
possibly PPARβ, appeared co-ordinately regulated by
diet depending on genotype, while PPARγ was not
affected [9]. In intestine, however, expression of PPARα
and PPARβ was not affected by either diet or genotype,
while PPARγ was up-regulated by dietary VO, signifi-
cantly in Fat fish. This suggests that dietary regulation of
lipid metabolism genes in fish intestine might differ to
mammals, where PPARα showed differential expression
in response to dietary EPA and DHA in murine intestine
[35]. Reasons for differential regulation of PPARs be-
tween salmon liver and intestine are unclear, but may be
due to different patterns of tissue expression. In plaice
and seabream, there was no nutritional regulation (fast-
ing/feeding) of PPARs in the intestine, where PPARγ
was the dominant isotype, in contrast to liver where
PPARα was dominant [36]. PPARγ in both mammals
and fish is predominantly expressed in adipose tissue
and promotes adipocyte differentiation and lipid storage
[36-38]. In mammals, PPARγ activates the expression of
genes characteristic of mature adipocytes and adipogen-
esis, including FAS [37,38] and hence the expression of
PPARγ, up-regulated in salmon fed VO, might be related
to increased expression of FAS. However, increased
PPARγ expression was only significant in Fat fish
whereas FAS was significantly up-regulated only in Lean
salmon. As fish PPARγ is functionally the most different
of the three isotypes compared to mammalian PPARs,
and is expressed more widely in fish tissues that in
mammals, other mechanisms and functions may under-
lie the observed regulation [35].
In this study, the hypotriglyceridemic effect of LC-
PUFA, well established in mammals [39,40], was also
observed in salmon intestine. Lipogenesis was down-
regulated in FO-fed fish, as demonstrated by decreased
FAS expression (RT-qPCR) and the presence of a tran-
script containing a beta-ketoacyl synthase domain, a
component of FAS (microarray). The differences in FAS
expression were not as marked as in liver [9] and were
only significant in Lean fish but, together with the LC-
PUFA biosynthesis data, demonstrate the active role of
salmon intestine in lipid metabolism [21]. However, des-
pite up-regulation of lipogenesis by dietary VO, lipid ac-
cumulation in enterocytes was lower than in fish fed FO,
contrary to previous reports of VO promoting lipid ac-
cumulation in enterocytes [16-18].In contrast, the hypotriglyceridemic effect of LC-PUFA
did not involve the typical increase in β-oxidation [39],
reported in mice intestine [36,40]. As in liver, no changes
were observed in the expression of β-oxidation genes car-
nitine palmitoyltransferase I (CPT1) and acyl-CoA oxi-
dase (ACO) [10]. Nonetheless, effects of dietary lipid on
energy metabolism were observed in intestine. In particu-
lar, UCP and transcripts involved in the mitochondrial
electron transport chain, including components of cyto-
chrome c oxidase, NADH1 and ubiquinol-cytochrome c
reductase complexes, and the mitochondrial metabolite
transporter SCaMC-2, were slightly down-regulated by
dietary VO, possibly suggesting reduced energetic metab-
olism. EPA may act as a mitochondrial proliferator in
both rat and salmon liver [41,42], which might also ex-
plain this result.
Vegetable oils as potential sources of contaminants in
alternative diets for aquaculture?
The use of FO in feeds has also been questioned in rela-
tion to levels of persistent organic pollutants, POPs [43],
whereas VO are generally considered safer alternatives to
dietary FO [44]. However, results suggested that VO had
greater impact on xenobiotic metabolism in salmon in-
testine than FO, with the transcriptome and proteome
both showing up-regulation of transcripts and proteins
involved in detoxification and protection from oxidative
stress in fish fed VO. This was surprising, considering ex-
pression of these genes has been associated with FO sup-
plementation and higher levels of organic contaminants
and/or increased peroxidative susceptibility of LC-PUFA
[22,45,46]. In particular, and linked to a detoxification
role, up-regulation of CYP1A transcript and epoxide
hydrolase 2 (EPHX2) protein was found in fish fed VO.
Cytochrome P450 1A metabolizes many exogenous and
endogenous molecules, including pollutants (e.g., poly-
chlorinated biphenyls-PCBs, polycyclic aromatic hydro-
carbons-PAHs, dioxins and dibenzofurans) as well as
several metabolic products (e.g., steroids, bile acids). Its
expression is sensitive to low levels of contaminants and
therefore it is a commonly used marker [47,48]. Lipid
peroxidation and antioxidant enzymes are also biomar-
kers for environmental xenobiotic contamination in fish,
as the catalytic actions of detoxifying enzymes like
CYP1A produce high levels of reactive oxygen species
(ROS) [49,50]. We observed up-regulation of CAT and of
a selenoprotein transcript, as well as of HPX and PRDX1
proteins in salmon fed VO. CAT and PRDX1 catalyze the
decomposition of hydrogen peroxide [51], hemopexin
prevents heme-mediated oxidative stress [52], and sele-
noproteins have diverse roles, including selenium trans-
port and antioxidant defense [53]. Expression of other
genes involved in protection from oxidative stress like
GST and SOD were not affected, but MT-A was down-
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sides having an antioxidant role, also protects against
heavy metal toxicity and maintains physiological zinc
homeostasis [54] and hence could be responding to con-
taminants more abundant in FO (e.g., heavy metals) [55].
Previous analysis of contaminants in comparable feeds
using the same standard FO and a similar VO blend,
showed that levels of several POPs, including organo-
chlorine pesticides, and heavy metals were substantially
lower, but polycyclic aromatic hydrocarbons (PAH) were
10-fold increased in the VO diet compared to the FO
diet [55]. PAH derive from incomplete combustion of
organic compounds and can be found in high concentra-
tions in fats, including VO, through multiple routes of
contamination, before, during or after oil processing
[56]. They are metabolized by both CYP1A1 and
EPHX2, among other enzymes, and CYP1A1 is induced
by PAH in mammals [57]. Therefore, higher PAH levels
in the VO diet might explain, at least partly, the results
obtained in the present study although, unlike POPs,
PAHs are not persistent and are readily eliminated from
fish tissues [58].
High doses of PAH result in significant intestinal
hyperplasia in fish, with an increase in cell proliferation
and faster epithelial turnover [59]. Previous studies on
intestinal gene expression in fish indicated a reduction
in cell proliferation or differentiation associated with
dietary FO replacement by VO [21,22], possibly due to
lower levels of membrane LC-PUFA and reduced oxida-
tive stress [22]. In the present study, no major impact on
cell proliferation was apparent in the intestinal transcrip-
tome or proteome data. Two transcripts related to cell
proliferation, PA2G4 and cyclin G1, were slightly down-
regulated in fish fed VO, but in mammals these have op-
posing effects [60,61] and, furthermore, two mammalian
PA2G4 isoforms have been shown to have opposite
effects in cellular proliferation [62] and hence results are
inconclusive.
Previously, expression of caspases, effectors of con-
trolled cell death or apoptosis, was affected by replace-
ment of dietary FO by VO in fish [21,22]. Apoptosis is
particularly important in organs with high rates of cellu-
lar turnover such as intestine but, in addition to main-
taining normal gut function, apoptosis may be affected by
pathological or toxic conditions, including those induced
by environmental chemical contaminants [63,64]. In the
present study, expression of CASP3B was up-regulated
in salmon fed VO, particularly in the Lean family group
and a similar, non-significant trend was observed for
CASP6A/B. As ROS are important signalling molecules
in apoptotic processes, these results could be linked to a
cytotoxic effect causing increased oxidative stress in VO
[64]. Relevant to the above was the up-regulation of
galectin 2 (LGALS2) in the proteome of salmon fed VO.Galectins are pleiotropic regulators of immune functions
and are up-regulated by injury and infectious conditions,
have well-recognized modulatory roles in mammalian
intestinal inflammatory diseases, and their mode of ac-
tion involves induction of apoptosis [65,66]. The lack of
major effects on cell proliferation and only slight up-
regulation of CASP3 and LGALS2 suggests that any
contaminant doses experienced by the fish were unlikely
to have caused any serious morphophysiological damage
in the intestine. As similar trends were not seen in the
hepatic transcriptome of these individuals [9], this may
suggest intestine can potentially metabolize and detoxify
xenobiotics present in the diet. Furthermore, there were
no growth or general performance issues with these fish
[5]. Therefore, the data do not imply abnormal gastro-
intestinal functions or effects on final product quality.
Effect of genotype in intestinal transcriptome
and proteome
Contrary to diet, genotype did not have a major impact
on metabolism genes, apart from transcripts related to
the proteasomal degradation pathway including a strong
down-regulation of PSMB8 in Lean fish, particularly fed
VO. This gene has been recently found to have a mo-
lecular evolution history that suggests a very strong se-
lective pressure for its functional dimorphism to be
maintained in vertebrates [67]. Two different alleles, A-
type and F-type, can be found in basal vertebrate species,
including Atlantic salmon. The PSMB8F lineage was lost
in common ancestors of higher teleosts and tetrapods
but was then independently revived de novo through the
appearance of F-type alleles within the PSMB8A lineage.
In this study we did not find evidence of significant dif-
ferences between families groups for the A-type allele in
the transcriptomic analysis as the probe showing signifi-
cant variation between families in the microarray corre-
sponded to the PSMB8F allele. Hence, it was also the
F-type transcript that was validated by RT-qPCR, using
type-F specific primers. However, further studies would
be required to confirm this and to assess the functional
significance of this result. On the other hand, expression
of PSMB1 was down-regulated in the intestine proteome
of Lean fish. Proteolysis through this pathway is essential
for many cellular processes, including the cell cycle, sig-
nalling, cellular defence and responses to oxidative stress
[68]. Therefore, this response might be related to de-
fence against cellular stress, as another difference be-
tween the two family groups was related to xenobiotic
and oxidant metabolism. Apart from lower expression of
a CYP1A transcript in Lean fish, two proteins with anti-
oxidant roles, HPX and PRDX, were down-regulated in
the proteome of Lean compared to Fat fish. Alpha glo-
bin, or haemoglobin alpha (HBA), a major component of
blood and potent mediator of oxidative stress, can have
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complex interactions in H2O2-rich environments [69].
However, given its opposite regulation to HPX, whose
main role is to scavenge heme and protect from its toxic
effects [52], up-regulation of HBA in Lean fish may indi-
cate heme-mediated oxidative stress.
The apoptotic pathway may be differentially affected
by genotype, with down-regulation of CASP3, VDAC2
and ANXA4 in the Lean family group, the latter two
transport proteins having well-recognized roles in apop-
tosis [70,71]. In contrast, heat shock proteins that pro-
tect against environmental stresses were increased in the
intestine transcriptome and proteome of Lean salmon.
This response could be associated with the observed
changes in the ubiquitin-proteasome degradation sys-
tem, as the systems have been functionally coupled in
mammals. Thus, moderate exposure to a heat shock can
cause a transient increase in intracellular proteolysis by
the ubiquitin-proteasome pathway, followed by a phase
of slower or even inhibited protein degradation [72,73].
Furthermore, Pirkkala et al. [74] demonstrated transcrip-
tional induction of heat shock genes when proteasome
activity was down-regulated. However, judging by the
fold-changes, these effects are only relevant when fish
were fed VO, and hence could be more related to dietary
changes. Collectively, the data may indicate higher sensi-
tivity of Lean fish to environmental or endogenous stres-
ses due to replacement of dietary FO by VO.
The predominant influence of genotype was in the ex-
pression of intestinal transcripts of structural proteins,
particularly collagen alpha chains, but also osteonectin,
TAGLN, troponin I and keratocan, which were up-
regulated in Lean fish, whereas troponin C was down-
regulated. Furthermore, CNN1 and TAGLN were
down-regulated in the intestinal proteome in Lean fish.
Collagen, the main component of connective tissue,
helps to maintain the structural integrity of tissues [75],
while osteonectin is an extracellular matrix glycoprotein
with high affinity towards collagen and whose expression
has been associated with remodelling processes in tis-
sues, including human intestine during development/
morphogenesis and in diseased mucosa [76]. Troponin,
TAGLN and CNN1 are all involved in actin binding,
actin-myosin interaction and muscle contraction. The
inverse regulation of troponins is not conflicting as they
have different roles in actomyosin cross-bridge forma-
tion and contraction; binding of troponin C to Ca2+
induces conformational changes that counteract the in-
hibitory action of troponin I [77]. Expression of TAGLN
transcript and protein showed opposite effects but a lack
of correlation between transcriptomic and proteomic
data is not unprecedented [78]. As discussed above, this
result might also be explained by the presence of similar
duplicated genes in Atlantic salmon that are regulateddifferently. Transcriptomic results were validated by RT-
qPCR for COL1A2, although only significantly when fish
were fed the VO diet, for which fold changes were
higher. In addition, in the microarray results differences
in expression of structural proteins between family
groups were consistently more accentuated in fish fed
VO which could suggest a cumulative effect of diet. Fur-
thermore, MYO was up-regulated in fish fed VO com-
pared to FO but only in Lean fish (RT-qPCR), and
significant diet × genotype interactions were found for
alpha-actinin 1, tubulin beta-2 chain and procollagen-
lysine 2-oxoglutarate 5-dioxygenase 2 (Additional file 1),
which were up-regulated in Lean salmon, compared to
Fat, but only when fed VO. In cod, replacement of FO
by VO resulted in changes in intestinal expression of
structural genes with the potential to alter the structural
and mechanical properties of the intestinal muscle layer,
including a range of actin-binding transcripts [21].
The present study is the first investigation of the influ-
ence of genetic background of families with different
flesh adiposity phenotypes on intestinal gene expression
of a fish species. Effects were subtle and consequently
their potential impacts difficult to fully assess. However,
if genetic selection for families better adapted to alterna-
tive formulations is an approach taken in the future, the
potential for genotype-specific differences being exacer-
bated when VO replaces dietary FO should be further
examined to assess the consequences of these changes in
intestinal gene expression.
Conclusions
Metabolic activity, particularly lipid and energy, of intes-
tinal tissue responded to dietary lipid composition but
was also affected by genotype. The LC-PUFA biosyn-
thesis pathway, typically up-regulated when salmon are
fed VO, was especially influenced by genetic back-
ground. The Lean fish showed an enhanced response to
low dietary n-3 LC-PUFA and the expression of Δ5fad,
Δ6fad, elovl5b and elovl2 in the intestine showed high
plasticity and was reflected in tissue biochemical com-
position indicating that their transcriptional regulation
might be under feedback control by n-3 LC-PUFA,
mainly DHA. Lower n-3 LC-PUFA in VO increased lipo-
genesis in Lean salmon, assessed by expression of FAS,
while β-oxidation appeared unaffected, although tran-
scripts involved in mitochondrial respiratory or electron
transport chains were down-regulated, suggesting
reduced activity in fish fed VO. Higher expression of
genes and proteins involved in xenobiotic metabolism
(CYP1A and EPHX2), antioxidant defence (CAT, HPX
and PRDX1), and apoptosis (Casp3B) were observed in
VO-fed fish, suggesting they might be responding to
higher levels of contaminants, particularly PAH, in the
diet. However, the intestine appeared able to metabolize
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the diet without major deleterious effects. Nonetheless,
the data suggest that further attention should be given
to contaminants in VO in the future. On the other hand,
the data indicate potential genotype-specific differences
in the response of the intestinal transcriptome and
proteome to dietary VO. These include potential
changes in structural properties of the intestinal layer
and defence against cellular stress suggesting the Lean
group was more susceptible to diet-induced oxidative
stress. Considering the possibility of selecting families
better adapted to alternative diet formulations, and the
central role of intestine as a major barrier to nutrients,
contaminants and pathogens, greater attention should
be given to this organ when evaluating the effects of diet
and genotype.
Methods
Feeding trial and sampling
A dietary trial was conducted using two genetically char-
acterized groups of Atlantic salmon (Salmo salar) post-
smolts comprising full-sib families selected from a
breeding program (Landcatch Natural Selection Ltd., Ar-
gyll, Scotland). The choice of the family groups was
based on estimated breeding values (EBVs) of the par-
ents for high or low flesh adiposity, assessed by Torry
Fatmeter (Distell Industries, West Lothian, UK), a trait
that was found to have a heritability ranging from 0.17
to 0.39 in this dataset. The two groups were created
from four unrelated full-sib families; two families from
the extreme lower end of the EBV distribution for flesh
lipid content (Lean) and two families from the extreme
upper end of the distribution (Fat). The average EBV for
the lipid content of the Fat families was 2.00 percentage
units higher than that of the Lean families, representing
a standardised selection differential of 2.33 standard
deviations. Assessment of the flesh and visceral lipid
contents at the end of the trial confirmed differences in
adiposity between the groups [5].
Two thousand fish of each group were stocked into
eight 12 x 5m3 net pens at the Ardnish Fish Trials Unit
(Marine Harvest Scotland, Lochailort, Scotland; 500 fish
pen-1). Duplicate pens of each group were fed one of
two experimental diets (Skretting ARC, Stavanger, Nor-
way) containing 25-32% fish meal, 40-45% plant meals
and 27.5-30% oil (percentages varying according to pellet
size) supplied either as standard northern FO or as a VO
blend comprising rapeseed, palm and Camelina oils in a
ratio of 5:3:2. Diets were formulated to fully satisfy the
nutritional requirements of salmonid fish [79] and con-
tained similar levels of PUFA but different n-3 and n-6
PUFA contents, 25.3% and 4.6% in the FO diet and
13.4% and 17.1% in the VO diet, respectively [5]. After
55 weeks, 25 fish per pen were sampled 24 h after thelast meal. Fish were killed by a blow to the head follow-
ing anaesthesia, and intestinal tissue (pyloric caeca) col-
lected, immediately frozen in liquid nitrogen and stored
at −70°C prior to analyses. Further details can be found
in Bell et al. [5].
Lipid extraction and fatty acid analyses
Total lipid from 1 g of intestine of four fish per treat-
ment was extracted and determined gravimetrically [80],
and fatty acid methyl esters (FAME) prepared by acid-
catalysed transesterification of total lipid [81]. FAME
were separated and quantified by gas chromatography as
described in detail previously [5]. Significant differences
in intestinal fatty acid composition were determined by
two-way ANOVA (p<0.05) using the SPSS 16.0 statistical
package (SPSS Inc., Chicago IL, USA).
RNA extraction and purification
Intestinal tissue (0.2 g) from six individuals per experi-
mental group was homogenised in 2mL TRI Reagent
and total RNA isolated following manufacturer’s instruc-
tions (Ambion, Applied Biosystems, Warrington, U.K.).
RNA quantity and quality (integrity and purity) were
assessed by gel electrophoresis and spectrophotometry
(NanoDrop ND-1000, Thermo Scientific, Wilmington,
U.S.A.), and 100 μg of total RNA from each sample fur-
ther cleaned by mini spin-column purification (RNeasy
Mini Kit, Qiagen, Crawley, UK).
Microarray hybridizations, image processing and
statistical analysis
The TRAITS/SGP (v.2.1) salmon 17k cDNA microarray
described by Taggart et al. [33] was used (ArrayExpress
accession: A-MEXP-1930). A dual-labelled experimental
design was employed, with each sample being competi-
tively hybridised against a common pooled-reference.
The experiment comprised 2 genotypes (Lean/Fat) × 2
diets (VO/FO) × 6 biological replicates. Indirect labelling
was employed for preparing the microarray targets.
Antisense amplified RNA (aRNA) was produced from
500 ng of purified total RNA per sample using the
Amino Allyl MessageAmpTM II aRNA Amplification
Kit as per manufacturer’s instructions (Ambion, Applied
Biosystems), followed by Cy3 (for samples) or Cy5 (for
pooled reference) fluor (GE HealthCare, Buckingham-
shire, U.K.) incorporation through dye-coupling reaction
[10]. Microarray hybridizations were performed in a
Lucidea semi-automated system (GE Healthcare) with-
out pre-hybridization. For each array, every labelled bio-
logical replicate and corresponding pooled reference (40
pmol each dye, c. 150 ng aRNA) were combined and added
to the hybridization solution. Two post-hybridization
automatic washes followed by six manual washes to a final
stringency of 0.1× SSC (EasyDipTM Slide staining system;
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scanning.
Scanning was performed at 10 μm resolution using an
Axon GenePix 4200AL Scanner (MDS Analytical Tech-
nologies, Wokingham, Berkshire, U.K.). Laser power was
constant (80%) and “auto PMT” was enabled to adjust
each channel at less than 0.1% feature saturation and
Cy3/Cy5 mean intensity close to one. BlueFuse software
(BlueGnome, Cambridge, U.K.) was used to identify fea-
tures and extract fluorescence intensity values from TIF
images. The resulting fluorescence intensity data (Blue-
Fuse proprietary algorithm) and quality annotations for
the 17,102 gene features were exported into the Gene-
Spring GX version 10.0.2 analysis platform (Agilent
Technologies, Wokingham, Berkshire, U.K.) after under-
going block Lowess normalization. All control features
were excluded from subsequent analyses. Data trans-
formation and quality filtering were as in Morais et al.
[9,10]. This gave a final list of 15,498 genes that were eli-
gible for statistical analysis. Experimental annotations
complied fully with minimum information about a
microarray experiment (MIAME) guidelines [82] and ex-
perimental hybridisations are archived on the EBI
ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/)
under accession number E-TABM-1173. Hybridization
data were analysed in GeneSpring by two-way ANOVA,
which examined the explanatory power of the variable
diet and genotype and the interaction between the two,
followed by Gene Ontology (GO) enrichment analysis of
the significant lists of features, at a significance level of
0.05. No multiple test correction was employed, as pre-
vious analyses, confirmed by RT-qPCR, indicated that
such corrections are over-conservative for this type of
data [9,32].
RT-qPCR gene expression analysis
Expression of selected genes, for microarray validation
and to further examine biological processes of interest,
was studied by reverse transcription quantitative real
time PCR (RT-qPCR), with target qPCR primer
sequences given in Additional file 2. In addition, amplifi-
cation of two reference genes, cofilin-2 and elongation
factor-1α (elf-1α), was performed. One μg of column-
purified total RNA per sample was reverse transcribed
into cDNA using the VersoTM cDNA kit (ABgene, Sur-
rey, U.K.) using a mixture of random hexamers (400ng/
μL) and anchored oligo-dT (500ng/μL) at 3:1 (v/v).
Negative controls (no enzyme) were performed to check
for genomic DNA contamination. A similar amount of
cDNA was pooled from all samples and the remaining
cDNA diluted 20-fold with water. RT-qPCR analysis used
relative quantification with the amplification efficiency of
each primer pair assessed by serial dilutions of the cDNA
pool. Amplifications were carried out in duplicate usinga Quantica machine (Techne, Cambridge, U.K.) in a final
volume of 20 μl containing 2–8 μl diluted cDNA, 0.5 μM
of each primer and 10 μl AbsoluteTM QPCR SYBRW
Green mix (ABgene), with a systematic negative control
(NTC-non template control). The qPCR profiles con-
tained an initial activation step at 95°C for 15 min, fol-
lowed by 30–40 cycles: 15 s at 95°C, 15 s at the specific
primer pair annealing temperature (Ta; Additional file 2)
and 15 s at 72°C. After amplification, a melt curve was
performed confirming a single product in each reaction,
RT-qPCR product sizes checked by agarose gel electro-
phoresis, and identity of amplicons confirmed by sequen-
cing. Gene expression was analysed using the relative
expression software tool (REST 2008, http://www.gene-
quantification.info/), employing a pair wise fixed reallo-
cation randomisation test (10,000 randomisations) with
efficiency correction [83].
Protein extraction and labelling
Six intestine samples (100 mg) per treatment were rap-
idly disrupted by homogenization and sonication on ice
in 1 ml of DIGE lysis/labeling buffer (7M Urea, 2M Thio-
urea, 4% CHAPS and 30mM Tris, pH 8.5) in the pres-
ence of 10 μl of a protease inhibitor cocktail (ref. P8340,
Sigma-Aldrich) and 4μl of 250 mM EDTA. After centri-
fugation at 12,000 × g for 20 min at 4°C, the supernatant
was recovered and protein concentration determined
(Quick Start Bradford Protein Assay Kit, ref. # 500–0202,
Bio-Rad). Protein (500 μg) was purified by precipitation
(ReadyPrepTM 2-D Cleanup kit, Bio-Rad) and the pellet
re-suspended in DIGE lysis/labeling buffer at ~5μg/μl.
Samples were labelled using CyDye DIGE fluors
(5nmol labelling kit; GE Healthcare), following manufac-
turer’s instructions. Three of the experimental replicates
of each treatment (50 μg protein with pH corrected to
8.0-8.5) were labelled individually with 400 pmol Cy3
and the remaining three with 400 pmol Cy5. In addition,
equal amounts of all experimental samples were pooled
and 600 μg of protein (50 μg per 2-D gel) were batch-
labelled with Cy2. The three labelled samples, corre-
sponding to two experimental samples and one internal
reference pool, were then combined to have in each 2-D
gel samples corresponding to fish fed either FO or VO
within the same family group.
Two-dimensional (2-D) polyacrylamide gel electrophoresis
Rehydration buffer (ReadyPrep 2-D starter kit, Bio-Rad)
containing 0.2% DTT was added to the pooled protein
samples to a final volume of 450 μl, which were loaded
onto Immobiline DryStrip pH 3–11 NL, 24 cm IPG strips
(GE Healthcare) by passive rehydration at room
temperature overnight in the dark. Proteins were sepa-
rated in the first dimension by isoelectric focusing at 20°C
(Ettan IPGphor, GE Healthcare), applying increasing
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period of 3 h, then keeping the applied tension at a con-
stant 1000 V for 1 h, followed by a further increase to
8000 V over 90 min, maintaining this voltage for almost
9 h (total of 79,200 Vh). After isoelectric focusing the
strips were equilibrated in two 40 min steps using
50mM Tris–HCl pH 8.8, 6M urea, 30% glycerol, 2% SDS
buffer, to which 2 % DTT (w/v) and 2.8% iodoacetamide
(GE Healthcare) were added to produce reducing and al-
kylating buffers, respectively. The strips were loaded
onto a 12.5% acrylamide gel cast between low fluores-
cence glass cassettes (EttanDALTsix gel caster system,
GE Healthcare). The strips were overlaid with ReadyPrep
Overlay Agarose (Bio-Rad) and the six gel cassettes run
in the EttanDALT system in two steps: at 60 mA, 80 V,
6 W (upper limits) for 1 h, and then 240 mA, 500 V,
78 W until the bromophenol blue dye front had run to
~1 cm above the bottom of the gels. Laemmli buffers
(250mM Tris, 1.92M glycine, 1% SDS) were used in the
lower (1X) and upper (2X) chambers, respectively.
Gel imaging and analysis
Labelled gels were scanned using a Typhoon TRIO (GE
Healthcare) and Cy2, Cy3 and Cy5 images acquired
using 520BP40, 580BP30 and 670BP30 laser emission fil-
ters, respectively, at 500 PMT and 100 μm resolution.
Images were cropped to remove extraneous areas prior
to analysis (ImageQuantTL, GE Healthcare), and image
analysis performed using DeCyder V7.0 (GE Healthcare).
The estimated number of spots for each co-detection
procedure was set at 10,000 and an exclusion filter was
applied to remove spots with a volume lower than
30,000. Differential expression of protein spots was
examined by two-way ANOVA at a significance level of
0.05. After verifying that significant spots were well
matched across the gels, two pick lists were generated
with a total of 22 and 45 spots for the diet and genotype
factors, respectively (Figure 1; Additional files 3 and 4).
Spot picking and protein identification by peptide
fragment fingerprinting
Four preparative gels were run under the conditions
described above but with higher amounts of protein (600
and 1000 μg). They were stained with colloidal Coomas-
sie and, whenever possible, spots were excised and
sequenced in the Mass Spectrometry Laboratory ITQB-
UNL (Oeiras, Portugal), where in-gel digestion and ex-
traction of the proteins from the gel was performed, fol-
lowed by micropurification, and peptides identified by
mass spectrometry (using an Applied Biosystems (ABI)
4800 MALDI TOF/TOF Analyzer). The search engine
MASCOT was then used to identify and confirm protein
ID’s from the peptide mass fingerprinting (PMF; MS) and
peptide fragment fingerprinting (PFF; MS/MS) data.Additional files
Additional file 1: Intestine transcripts corresponding to the top 100
most significant features exhibiting a significant diet × family
interaction.
Additional file 2: Primers used for RT-qPCR analyses [84-89].
Additional file 3: 2D-gels pick list for the factor diet.
Additional file 4: 2D-gels pick list for the factor genotype.
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